Clover Health Investments (CLOV) Change in Accured Expenses (2020 - 2026)

Clover Health Investments has reported Change in Accured Expenses for 7 years, with the latest figure at $15.2 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 478.76% year-over-year to $15.2 million; the trailing twelve-month figure through Mar 2026 stood at $16.2 million (up 220.91% YoY), and the FY2025 full-year result was -$3.1 million, down 54.85% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $15.2 million, up from -$1.4 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $15.2 million in Q1 2026, with the low at -$19.3 million in Q2 2023.
• Historically, Change in Accured Expenses has averaged $876647.1 across 5 years, with a median of -$678000.0 in 2022.
• The largest YoY upside for Change in Accured Expenses was 2313.42% in 2023 against a maximum downside of 8610.13% in 2023.
• Clover Health Investments' Change in Accured Expenses stood at -$2.0 million in 2022, then plunged by 191.83% to -$5.8 million in 2023, then tumbled by 184.42% to -$16.4 million in 2024, then surged by 91.28% to -$1.4 million in 2025, then jumped by 1165.36% to $15.2 million in 2026.
• The last three Change in Accured Expenses figures came in at $15.2 million (Q1 2026), -$1.4 million (Q4 2025), and -$7.7 million (Q3 2025), per Business Quant data.